NCT06184139

Brief Summary

To evaluate the effect of maternal age and body mass index (BMI) on oral misoprostol induction of labor for late-term pregnancies.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
104

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 18, 2023

Completed
13 days until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
27 days until next milestone

First Posted

Study publicly available on registry

December 28, 2023

Completed
4 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2024

Completed
Last Updated

December 28, 2023

Status Verified

December 1, 2023

Enrollment Period

1 month

First QC Date

November 18, 2023

Last Update Submit

December 14, 2023

Conditions

Keywords

Late-term pregnancybody mass indexageoral misoprostolcervical ripeninginduction of labor

Outcome Measures

Primary Outcomes (1)

  • Safety and tolerability of misoprostol for induction of labor

    Efficacy induction of labor for late term pregnancies according to age and BMI

    290 days of pregnancy

Interventions

Oral misoprostol for induction of labor in late term pregnancies

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

term (37 weeks or more of gestation) singleton pregnancies in women who have not had a previous cesarean delivery and a bishop score \< 7.

You may qualify if:

  • Late term pregnancies out of labor,
  • Bishop score \< 7

You may not qualify if:

  • labor (defined as presence of at least three painful uterine contractions every ten minutes),
  • uterine tachysystole (\>5 contractions within 10 minutes for two consecutive 10-minute periods),
  • hypertonic uterus,
  • abnormal CTG,
  • contraindications to vaginal delivery (fetal malpresentation such as breech presentation or transverse situation, fetal macrosomia, abnormally implanted placenta, active genital herpes infection, cervical cancer),
  • patients with parity \> 4,
  • medical contraindication to misoprostol (asthma, glaucoma),
  • women with previous hysterotomies.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Andrea Etrusco

Palermo, 90123, Italy

Location

MeSH Terms

Interventions

Misoprostol

Intervention Hierarchy (Ancestors)

Prostaglandins E, SyntheticProstaglandins, SyntheticProstaglandinsEicosanoidsFatty Acids, UnsaturatedFatty AcidsLipidsAutacoidsInflammation MediatorsBiological Factors

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

November 18, 2023

First Posted

December 28, 2023

Study Start

December 1, 2023

Primary Completion

January 1, 2024

Study Completion

January 1, 2024

Last Updated

December 28, 2023

Record last verified: 2023-12

Locations